Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Amazing opportunity with MU ! Keep it UP !!!
GLTA
Thinking NOT so with their forward looking statements.
There are always pull backs, but long term - MU is aces.
GLTA
Exactly. Who cares what they say.
MU $300 in 2 years… IMO
MU earnings 9/25 at 3:30 CMT.
Thursday will be good
Missed that 15min of $51 yesterday…
That was nuts only 15min then 44???
Glad to be in today MU !
Gold all time high so how’s GDXU go down??!!
Gold all time high so how’s JNUG go down??!!
DJT begins TV Streaming rollout !
“Trump Media & Technology Group (Nasdaq: DJT) (“TMTG” or the “Company”), operator of the social media platform Truth Social, announced today that the Company has commenced the phased rollout of its streaming platform, Truth+.
Today, TMTG begins moving existing beta testing of its Truth Social linear TV streaming to the Company’s new content delivery network (“CDN”). After rigorous stress testing, the initial streaming service is expected to become available to all Truth Social users on the Web, followed shortly by its rollout on Android and iOS.
Once the CDN is deployed and tested, a Truth+ streaming icon on the Truth Social platform will provide access to the streaming service. By clicking the icon, users will be able to access streaming content as stand-alone channels or in a separate picture-in-picture (“PiP”) window while scrolling on the Truth Social platform. iOS users will need to update their Truth Social app to access streaming. No updates or downloads will be required for Android or Web users.
The initial slate of streaming options is expected to include channels comprising news, commentary, weather, and lifestyle and entertainment. TMTG plans to expand programming as its streaming rollout continues, focusing on news, Christian content, and family friendly content. As part of its strategy, TMTG is continuing to work toward closing the previously announced perpetual licensing deal for CDN technology.
“First, we created Truth Social to provide a safe harbor for free speech on the Internet,” said TMTG CEO Devin Nunes. “Now, we’re establishing a reliable home for great TV content that is neglected by the big corporations or is at risk of cancellation—and we are securing our own tech stack and hardware infrastructure to make our new CDN uncancellable. I look forward, in the near future, to launching many enhancements and adding great, new content to the platform.”
The introduction of these channels is the initial phase of Truth Social’s TV streaming platform. The next phase is expected to feature the introduction of streaming apps integrated with the Truth Social platform that will offer enhanced features, including an interactive 14-day electronic guide, instant catch-up TV on any show broadcast in the previous 7 days, network DVR, video on demand, and more. Following that, TMTG plans to introduce apps that provide the ability to watch streaming content on in-home TV sets.
TMTG’s ultra-fast streaming technology will be powered through specially designed infrastructure with its own servers, routers, and proprietary software stack. Thus, TMTG will gain full control over its tech delivery stack for streaming across private network CDN, rendering the service uncancellable by Big Tech.”
GLTA
First I’ve seen.
I have 1500 shares and on July 2 I received $305.07 saying “JNUG dividend” !
Yes. I like my JNUG dividends just received!
GLTA
Hopefully hear timeline for interest cuts to push us UP…
Something fishy RIOT ??
There it is 1:16 on 6/6.
F’n thieves !!!
SCHABER: Buy back some shares to "increase shareholder value"...
Not continuous REVERSE SPLITS where only YOU benefit !!!
I will research legal actions along with all other victims...
SNGX PR 5/23/24:"Soligenix urges stockholders to vote FOR reverse-split"!
FU Shaber - you're a disgrace to the Medical Research community !
How & why Jim Cramer would every prmote your fake business !
Yep there it is SNGX:
Page 3 of 60. (skank Schaber...)
"The Board of Directors recommends that you vote FOR this proposal because the Board of Directors believes that, if
the number of shares of Common Stock cast is insufficient to constitute a quorum or approve any proposal, it is in the
best interests of the stockholders to enable the Board of Directors to continue to seek to obtain a sufficient number of
additional votes to constitute a quorum or approve the proposals, including the Reverse Stock Split Proposal."
SNGX seems legit with "$7.1m cash on 3/31/2024"? But PPS ???
"Dr. Schaber continued, "With approximately $7.1 million in cash at March 31, 2024, exclusive of the approximate $4.3 million in net proceeds from our recent financing and our non-dilutive government funding, we continue to manage cash burn very carefully to achieve our near-term milestones. We have a clear vision for the future, and we are actively pursuing new opportunities to create long-term value for our shareholders including but not limited to, partnership and merger and acquisition opportunities."
Soligenix Recent Accomplishments
1) On April 25, 2024, the Company announced it had received notice of intent to grant additional patents based on its patent application titled "Compositions and Methods of Manufacturing Trivalent Filovirus Vaccines" in the United Kingdom and South Africa, with other international jurisdictions pending. To view this press release, please click here.
2) On April 18, 2024, the Company announced the pricing of its public offering of 11,875,000 shares of common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 11,875,000 shares of common stock at a combined public offering price of $0.40 per share and accompanying warrants for aggregate gross proceeds of approximately $4.75 million, before deducting placement agent fees and other offering expenses. To view this press release, please click here.
3) On April 15, 2024, the Company announced the Office of Orphan Products Development of the U.S. FDA had granted orphan drug designation to the active ingredient in SuVax™, the subunit protein vaccine of recombinantly expressed SUDV glycoprotein, for "the prevention and post-exposure prophylaxis against SUDV infection." To view this press release, please click here.
4) On April 11, 2024, the Company announced the Office of Orphan Products Development of the U.S. FDA had granted orphan drug designation to the active ingredient in MarVax™, the subunit protein vaccine of recombinantly expressed MARV glycoprotein, for "the prevention and post-exposure prophylaxis against MARV infection." To view this press release, please click here.
5) On April 3, 2024, the Company announced it had received agreement from the EMA on the key design components of a confirmatory Phase 3 placebo-controlled study evaluating the safety and efficacy of HyBryte™ (synthetic hypericin) in the treatment of CTCL patients with early-stage disease. To view this press release, please click here.
Financial Results – Quarter Ended March 31, 2024
- Soligenix's revenues for the quarter ended March 31, 2024 were $0.1 million as compared to $0.3 million for the quarter ended March 31, 2023. Revenues primarily relate to government contracts and grants awarded in support of SGX943 for treatment of emerging and/or antibiotic-resistant infectious diseases; development of CiVax™, our vaccine candidate for the prevention of COVID-19, and evaluation of HyBryte™ for expanded treatment in patients with early-stage CTCL.
- Soligenix's net loss was $1.9 million, or ($0.18) per share, for the quarter ended March 31, 2024, as compared to $1.0 million, or ($0.36) per share, for the quarter ended March 31, 2023. The increase in net loss was primarily due to the recognition of an income tax benefit during the three months ended March 31, 2023 with no corresponding income tax benefit recognized during the three months ended March 31, 2024.
- Research and development expenses were $1.1 million as compared to $0.9 million for the quarters ended March 31, 2024 and 2023, respectively. The increase was primarily due to an increase in preliminary costs associated with the anticipated initiation of our Phase 2 study in Behçet's Disease and the second confirmatory Phase 3 CTCL trial.
- General and administrative expenses were $1.0 million and $1.2 million for the quarters ended March 31, 2024 and 2023, respectively. This decrease in general and administrative expenses is primarily attributable to a reduction in legal and professional fees associated with the reverse stock split of our issued and outstanding shares of common stock during the three months ended March 31, 2023.
- As of March 31, 2024, the Company's cash position, exclusive of the approximate $4.3 million in net proceeds from our recent financing, was approximately $7.1 million."
GLTA
...
..
.
SNGX sure showing breakdown !
Does SNGX 5/22 meeting doc show potential r/s? Again?
SNGX already did 1 reverse split but Schaber doesn’t care about PPS so allows to tank, dilute, reverse, repeat…
Good business. For him
Schaber such a skank dilute with .40 shares with supposed millions in cash on hand???
Definitely orchestrated pump with DUMP hard so far today…
Schaber only looking to keep his salary afloat by adding shares??
GLTA
Thanks. SNGX horribly short pop…
And down SNGX goes..
Too many prior “orphan grants” and nothing happens…
GLTA
JNUG been there before!
GLTA
Lookin good JNUG !
I even averaged down a bit
Wish I had more $$$ for DJT dip…
Down on 2m traded vs 20m daily average….
Hmmmmmm
Abstaraeniatet…
(Only swear I remember from Russia class)
Trump will prevail.
DJT will create wealth…
GLTA
That’s a poker face for sure.
This will likely exceed $50+ within the next 5 trading days…
And we can say 54, 64, 74, and 84 !!!
My shares are GTC at $110.50 !
GLTA
WTH with Bitcoin up $3k today
MARA looking like mud with Bitcoin up $3k
Agreed. I'm back in RIOT...
GLTA
Nice try Dr Shabby with repeat PR: "April 3, 2024 Randomized Study with 18 Weeks Continuous Treatment Expected to Replicate and Extend Results from the First, Statistically Significant Phase 3 Study"...
BS press release after yesterday 4/2 filing for your 16m share dilution AGAIN...
How LOW do you take SNGX ???
Schaber must need few bucks so planning another RS.
Nice business.
Jim Cramer should go down with this ship show as he promoted it….
Trump 2024 ! DJT on the way UP…
And by the way - everyone here in the USA will tell you - EVERY Frenchman is WRONG !!!
GLTA
There you have it...
Mainipulation here at DJT likely be same as reddit, and pop hard 2-3 days later...IMO?
GLTA
Agreed. This is just the everyday lull 11am-1pm EST....
After 3pm EST going to be interesting right in to after-hours...
GLTA